Effect of Early Versus Late Initiation of Edaravone Dexborneol on Neural Function in Patients With Acute Ischemic Stroke
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 212 participants.
Also called NCT05885919
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 212 participants
- Registry
-
NCT05885919
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT05885919. Randomized; triple masking; primary purpose treatment. Start 2023-07-01 (anticipated); primary completion 2024-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect of Early Versus Late Initiation of Edaravone Dexborneol on Neural Function in Patients With Acute Ischemic Stroke
- Acronym
- EARLYS
- Condition
- Ischemic Stroke, Acute
- Condition
- Treatment Outcome
- Intervention (Drug)
- Edaravone Dexborneol Concentrated Solution for injection
- Intervention (Drug)
- Edaravone Dexborneol placebo
- Lead sponsor
- Xiangya Hospital of Central South University
- Collaborator
- Jiangsu Simcere Pharmaceutical Co., Ltd.
Record details
- Record id
cardio:ct-nct05885919- Content hash
a5fe68a3b4780e801c6f5b5c6e9b48575e39e95256100b24b93aa729ab5e2189